|
CAR-T cells Infusion chimeric antigen receptor T cells Clinical Trials
2 actively recruiting trials
Pipeline
Early 1: 2
Top Sponsors
- The First Affiliated Hospital of Soochow University1
- Institute of Hematology & Blood Diseases Hospital, China1
Indications
- Cancer2
- Relapsed/Refractory Plasma Cell Leukemia1
- Relapsed/ Refractory Multiple Myeloma1
- Plasma Cell Leukemia1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.